Digital health technologies have the potential to increase efficiency and data capture, while creating exciting new ways to accelerate patient access, improve retention and increase diversity. The use of these capabilities can reduce patient burden, streamline study operations and collect previously unobtainable data – including real world data – to help accelerate the discovery, development and approval of new products. But, we know there is no “one size – fits all” solution to decentralizing a clinical trial.
In this presentation, Scott Scarola and Noolie Gregory discuss how thoughtful orchestration and seamless integration of innovative solutions throughout each stage of the product development lifecycle can result in solutions with the consistency and operational quality to deliver time after time.
Learn more about our Decentralized Solutions capabilities here.
